Amgen to acquire Five Prime Therapeutics for $1.9B
Amgen fundamentals
For this year Amgen 's (located in Thousand Oaks) revenue will be around 26.45 billion USD. This is according to the average of the analysts' estimates. This is slightly more than 2020's revenue of 25.42 billion USD.
Historical revenues and results Amgen plus estimates 2020
The analysts expect for 2021 a net profit of 9.7 billion USD. The majority of the analysts expects for this year a profit per share of 16.83 USD. The price-earnings-ratio equals 13.53.
Huge dividend Amgen
Per share the analysts expect a dividend of 6.93 USD per share. Thus the dividend yield equals 3.04 percent. The average dividend yield of the biotech companies is a moderate 0.37 percent.Newest target prices around 239 USD
The most recent recommendations for the biotech company are from JP Morgan, UBS and Citigroup .Amgen 's market capitalization is based on the number of outstanding shares around 134.68 billion USD. The Amgen stock was the past 12 months quite volatile. Since last March the stock is 11 percent higher. This year the stock price moved between 177 and 277 dollar.
Historical stock prices Amgen
Click here for dividend Amgen. At 21.00 the stock trades 0.93 percent higher at 227.73 USD.
Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
